Temat: "drug combination" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Estimating the impact of alternative programmatic cotrimoxazole strategies on mortality among children born to mothers with HIV: A modelling study.
Autorzy:: Mathur S; Blizard Institute, Queen Mary University of London, London, United Kingdom.
Smuk M; Blizard Institute, Queen Mary University of London, London, United Kingdom.
Evans C; Blizard Institute, Queen Mary University of London, London, United Kingdom.; Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.; Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom.
Wedderburn CJ; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom.; Department of Paediatrics and Child Health and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Gibb DM; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom.
Penazzato M; Department of Research for Health, Science Division, World Health Organization, Geneva, Switzerland.
Prendergast AJ; Blizard Institute, Queen Mary University of London, London, United Kingdom.; Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2024 Feb 20; Vol. 21 (2), pp. e1004334. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).
Typ publikacji:: Review; Journal Article
MeSH Terms:: Trimethoprim, Sulfamethoxazole Drug Combination*/therapeutic use
HIV Infections*/diagnosis
Child ; Female ; Humans ; Mothers ; Zimbabwe/epidemiology ; Mozambique/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.
Autorzy:: Dorkenoo AM; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo. .
Warsame M; School of Public Health and Community Medicine, University of Gothenburg, Gothenburg, Sweden.
Ataba E; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Hemou M; Service de Pédiatrie, Centre Hospitalier Universitaire Campus, Lomé, Togo.
Yakpa K; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Sossou E; Service des Laboratoires, Centre Hospitalier Universitaire Sylvanus Olympio Lomé, Lomé, Togo.
Mitigmsagou M; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Teou CD; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Caspar E; Institute of Parasitology and Tropical Diseases, Université de Strasbourg, UR7292 Dynamics of Host-Pathogen Interactions, 67000, Strasbourg, France.
Ma L; Biomics Platform, C2RT, Institut Pasteur, 75015, Paris, France.
Djadou KE; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Atcha-Oubou T; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Rasmussen C; Global Malaria Programme, World Health Organization, Geneva, Switzerland.
Menard D; Institute of Parasitology and Tropical Diseases, Université de Strasbourg, UR7292 Dynamics of Host-Pathogen Interactions, 67000, Strasbourg, France.; Malaria Genetics and Resistance Unit, Institut Pasteur, Université Paris Cité, INSERM U1201, 75015, Paris, France.; Malaria Parasite Biology and Vaccines, Institut Pasteur, Université Paris Cité, 75015, Paris, France.; Laboratory of Parasitology and Medical Mycology, CHU Strasbourg, 67000, Strasbourg, France.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Apr 03; Vol. 23 (1), pp. 92. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Quinolines*/pharmacology
Quinolines*/therapeutic use
Malaria, Falciparum*/drug therapy
Malaria, Falciparum*/epidemiology
Malaria, Falciparum*/parasitology
Malaria*/drug therapy
Piperazines*
Artemisinins*
Child ; Adult ; Humans ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Artemether, Lumefantrine Drug Combination/pharmacology ; Prevalence ; Togo/epidemiology ; Prospective Studies ; Artemether/therapeutic use ; Drug Resistance ; Tetrahydrofolate Dehydrogenase/genetics ; Biomarkers ; Drug Combinations ; Plasmodium falciparum/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.
Autorzy:: Bakari C; National Institute for Medical Research, Dar Es Salaam, Tanzania.; Swiss Tropical and Public Health Institute, Basel, Switzerland.
Mandara CI; National Institute for Medical Research, Dar Es Salaam, Tanzania.
Madebe RA; National Institute for Medical Research, Dar Es Salaam, Tanzania.
Seth MD; National Institute for Medical Research, Dar Es Salaam, Tanzania.
Ngasala B; Department of Parasitology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Kamugisha E; Catholic University of Health and Allied Sciences, Bugando Medical Centre, Mwanza, Tanzania.
Ahmed M; Catholic University of Health and Allied Sciences, Bugando Medical Centre, Mwanza, Tanzania.
Francis F; National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania.
Bushukatale S; Department of Parasitology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Chiduo M; National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania.
Makene T; Department of Parasitology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Kabanywanyi AM; Ifakara Health Institute, Dar Es Salaam Office, Dar Es Salaam, Tanzania.
Mahende MK; Ifakara Health Institute, Dar Es Salaam Office, Dar Es Salaam, Tanzania.
Kavishe RA; Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Muro F; Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Mkude S; National Malaria Control Program, Dodoma, Tanzania.
Mandike R; National Malaria Control Program, Dodoma, Tanzania.
Molteni F; Swiss Tropical and Public Health Institute, Basel, Switzerland.; National Malaria Control Program, Dodoma, Tanzania.
Chacky F; National Malaria Control Program, Dodoma, Tanzania.
Bishanga DR; Ifakara Health Institute, Dar Es Salaam Office, Dar Es Salaam, Tanzania.; Maternal and Child Survival Program, Jhpiego, Dar Es Salaam, Tanzania.; School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Njau RJA; Malariologist and Public Health Specialist, Dar Es Salaam, Tanzania.
Warsame M; University of Gothenburg, Gothenburg, Sweden.
Kabula B; PMI/Okoa Maisha Dhibiti Malaria, RTI International, Dar Es Salaam, Tanzania.; National Institute for Medical Research, Amani Research Centre, Muheza, Tanga, Tanzania.
Nyinondi SS; PMI/Okoa Maisha Dhibiti Malaria, RTI International, Dar Es Salaam, Tanzania.
Lucchi NW; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.; Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.
Talundzic E; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Venkatesan M; U.S. President's Malaria Initiative, USAID, Washington, DC, USA.
Moriarty LF; Malaria Branch, U.S. President's Malaria Initiative, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Serbantez N; U.S. President's Malaria Initiative, USAID, Dar Es Salaam, Tanzania.
Kitojo C; U.S. President's Malaria Initiative, USAID, Dar Es Salaam, Tanzania.
Reaves EJ; U.S. President's Malaria Initiative, US Centers for Disease Control and Prevention, Dar Es Salaam, Tanzania.
Halsey ES; Malaria Branch, U.S. President's Malaria Initiative, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Mohamed A; National Malaria Control Program, Dodoma, Tanzania.
Udhayakumar V; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.; Independenant Consultant, Decatur, Georgia.
Ishengoma DS; National Institute for Medical Research, Dar Es Salaam, Tanzania. .; Faculty of Pharmaceutical Sciences, Monash University, Melbourne, Australia. .; Harvard T.H Chan School of Public Health, Harvard University, Boston, MA, USA. .; Department of Biochemistry, Kampala International University, Dar Es Salaam, Tanzania. .; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Mar 09; Vol. 23 (1), pp. 71. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Artemisinins*/pharmacology
Artemisinins*/therapeutic use
Malaria, Falciparum*/epidemiology
Carubicin/*analogs & derivatives
Humans ; Lumefantrine/pharmacology ; Lumefantrine/therapeutic use ; Plasmodium falciparum/genetics ; Tanzania ; Artemether/therapeutic use ; Multidrug Resistance-Associated Proteins/genetics ; Artemether, Lumefantrine Drug Combination/pharmacology ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Biomarkers ; Drug Resistance/genetics ; Protozoan Proteins/genetics ; Protozoan Proteins/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019.
Autorzy:: Ngasala BE; Department of Parasitology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. .
Chiduo MG; National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania.
Mmbando BP; National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania.
Francis FT; National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania.
Bushukatale S; Department of Parasitology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Makene T; Department of Parasitology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Mandara CI; National Institute for Medical Research, Headquarters, Dar es Salaam, Tanzania.
Ishengoma DS; National Institute for Medical Research, Headquarters, Dar es Salaam, Tanzania.
Kamugisha E; Catholic University of Health and Allied Sciences, Bugando Medical Centre, Mwanza, Tanzania.
Ahmed M; Catholic University of Health and Allied Sciences, Bugando Medical Centre, Mwanza, Tanzania.
Mahende MK; Ifakara Health Institute, Dar-es-Salaam, Tanzania.
Kavishe RA; Kilimanjaro Christian Medical Centre, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Muro F; Kilimanjaro Christian Medical Centre, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Molteni F; National Malaria Control Program, Dodoma, Tanzania.
Reaves E; U.S. President's Malaria Initiative, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Kitojo C; U.S. President's Malaria Initiative, U.S. Agency for International Development, Dar es Salaam, Tanzania.
Greer G; U.S. President's Malaria Initiative, U.S. Agency for International Development, Dar es Salaam, Tanzania.
Nyinondi S; R.T.I. International, Dar es Salaam, Tanzania.
Kabula B; R.T.I. International, Dar es Salaam, Tanzania.
Lalji S; R.T.I. International, Dar es Salaam, Tanzania.
Chacky F; National Malaria Control Program, Dodoma, Tanzania.
Njau RJ; Muhimbili University of Health and Allied Science, Dar es Salaam, Tanzania.
Warsame M; Gothenburg University, Gothenburg, Sweden.
Mohamed A; National Malaria Control Program, Dodoma, Tanzania.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Apr 09; Vol. 23 (1), pp. 101. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/adverse effects
Malaria, Falciparum*/drug therapy
Artemisinins*/adverse effects
Malaria*/drug therapy
Child ; Humans ; Infant ; Artemether, Lumefantrine Drug Combination/adverse effects ; Tanzania ; Reinfection/chemically induced ; Reinfection/drug therapy ; Prospective Studies ; Drug Combinations ; Artemether/therapeutic use ; Amodiaquine/therapeutic use ; Treatment Outcome ; Plasmodium falciparum

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Antimicrobial Resistance Patterns in Patients with Vaginal Discharge: A 2019-2022 Analysis at the National Health Laboratory in Eritrea.
Autorzy:: Hussein K; Department of Obstetrics and Gynecology, Orotta College of Medicine and Health Sciences, Orotta National Referral Maternity Hospital, Ministry of Health, Asmara, Eritrea.
Tesfai B; Department of Obstetrics and Gynecology, Orotta College of Medicine and Health Sciences, Orotta National Referral Maternity Hospital, Ministry of Health, Asmara, Eritrea.
Frezgi O; Department of Obstetrics and Gynecology, Orotta College of Medicine and Health Sciences, Orotta National Referral Maternity Hospital, Ministry of Health, Asmara, Eritrea.
Hayelom H; Microbiology Department, National Health Laboratory, Ministry of Health, Asmara, Eritrea.
Gebremeskel Y; Microbiology Department, National Health Laboratory, Ministry of Health, Asmara, Eritrea.
Werede A; National Medicines and Food Administration, Ministry of Health, Asmara, Eritrea.
Gebremariam H; Dekemhare Hospital, Zoba Debub, Ministry of Health, Dekemhare, Eritrea.
Kibreab F; Ministry of Health, Division of the Center for Health Research and Resources, Asmara, Eritrea.
Hamida ME; Unit of Medical Microbiology, Orotta College of Medicine and Health Sciences, Asmara, Eritrea.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2024 Mar 28; Vol. 2024, pp. 7193490. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Bacterial Agents*/pharmacology
Anti-Bacterial Agents*/therapeutic use
Vaginal Discharge*
Female ; Humans ; Clindamycin ; Vancomycin ; Trimethoprim, Sulfamethoxazole Drug Combination ; Staphylococcus aureus ; Escherichia coli ; Eritrea ; Rifampin ; Retrospective Studies ; Drug Resistance, Bacterial ; Oxacillin ; Gram-Positive Bacteria ; Tetracycline/pharmacology ; Streptococcus ; Ampicillin ; Penicillin G ; Microbial Sensitivity Tests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Frequency of drug-resistant bacterial isolates among pregnant women with UTI in maternity and children's hospital, Bisha, Saudi Arabia.
Autorzy:: Al-Shahrani GS; Faculty of Applied Medical Sciences, University of Bisha, 255, Al Nakhil, 67714, Bisha, Saudi Arabia.
Belali TM; Faculty of Applied Medical Sciences, University of Bisha, 255, Al Nakhil, 67714, Bisha, Saudi Arabia. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 28; Vol. 14 (1), pp. 7397. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Bacterial Agents*/pharmacology
Anti-Bacterial Agents*/therapeutic use
Urinary Tract Infections*/drug therapy
Urinary Tract Infections*/epidemiology
Urinary Tract Infections*/microbiology
Pregnancy ; Child ; Female ; Humans ; Pregnant Women ; Saudi Arabia/epidemiology ; Cross-Sectional Studies ; Gram-Negative Bacteria ; Gram-Positive Bacteria ; Bacteria ; Piperacillin, Tazobactam Drug Combination/therapeutic use ; Escherichia coli ; Gentamicins/pharmacology ; Hospitals ; Microbial Sensitivity Tests ; Drug Resistance, Bacterial

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Copayment mechanism in selected districts of Uganda: Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets.
Autorzy:: Ocan M; Department of Pharmacology & Therapeutics, College of Health Sciences, Makerere University, Kampala, Uganda.
Nambatya W; Department of Clinical Pharmacy, College of Health Sciences, Makerere University, Kampala, Uganda.
Otike C; Data Department, Joint Clinical Research Centre, Lubowa, Kampala, Uganda.
Nakalembe L; Department of Pharmacology, Soroti University, Soroti, Uganda.
Nsobya S; Department of Pathology, College of Health Sciences, Makerere University, Kampala, Uganda.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 27; Vol. 19 (3), pp. e0295198. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/therapeutic use
Artemisinins*/therapeutic use
Malaria*/drug therapy
Humans ; Uganda ; Cross-Sectional Studies ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Artemether/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda: stakeholder engagement meeting report.
Autorzy:: Hill J; Institut de Recherche Clinique du Benin (IRCB), Cotonou, Benin. .; Pokaż więcej
Corporate Authors:: PDMC Saves Lives Consortium
Źródło:: Malaria journal [Malar J] 2024 Mar 27; Vol. 23 (1), pp. 89. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Meta-Analysis; Journal Article
MeSH Terms:: Antimalarials*/therapeutic use
Malaria*/prevention & control
Malaria*/drug therapy
Anemia*/drug therapy
Artemisinins*
Child ; Humans ; Kenya ; Uganda ; Aftercare ; Malawi ; Benin ; Patient Discharge ; Stakeholder Participation ; Artemether/therapeutic use ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Pyrimethamine/therapeutic use ; Drug Combinations ; Chemoprevention

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
Autorzy:: McKellar MS; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, P.O. Box 102359, Durham, NC, 27710, USA. .
Des Marais AC; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Chen H; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Choi Y; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Lilly R; North Carolina Harm Reduction Coalition, Wilmington, NC, USA.; Port City Harm Reduction, Wilmington, NC, USA.
Ayers D; Queen City Harm Reduction, Charlotte, NC, USA.
Bennett J; North Carolina Harm Reduction Coalition, Wilmington, NC, USA.
Kestner L; Queen City Harm Reduction, Charlotte, NC, USA.
Perry B; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Poley S; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Corneli A; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, P.O. Box 102359, Durham, NC, 27710, USA.; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Meade CS; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.; Wake Forest University, Winston-Salem, NC, USA.
Sachdeva N; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; North Carolina Association of County Commissioners, Raleigh, NC, USA.; Pokaż więcej
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Mar 26; Vol. 21 (1), pp. 69. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: Anti-HIV Agents*/therapeutic use
HIV Infections*/prevention & control
Opioid-Related Disorders*/drug therapy
Pre-Exposure Prophylaxis*
Substance Abuse, Intravenous*/drug therapy
Humans ; Male ; Buprenorphine, Naloxone Drug Combination/therapeutic use ; Pilot Projects ; Female

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Safety and efficacy of pyronaridine-artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study.
Autorzy:: Ramharter M; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; German Centre for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel, Hamburg, Germany.; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Djimde AA; Malaria Research and Training Center (MRTC), Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Borghini-Fuhrer I; Medicines for Malaria Venture, Route de Pré-Bois 20, 1215, Geneva 15, Switzerland.
Miller R; Artemida Pharma, Stevenage, UK.
Shin J; Shin Poong Pharm. Co. Ltd, Seoul, Korea.
Aspinall A; Medicines for Malaria Venture, Route de Pré-Bois 20, 1215, Geneva 15, Switzerland.
Richardson N; Magenta Communications Ltd, Abingdon, UK.
Wibberg M; DATAMAP GmbH, Freiburg, Germany.
Fleckenstein L; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, USA.
Arbe-Barnes S; Artemida Pharma, Stevenage, UK.
Duparc S; Medicines for Malaria Venture, Route de Pré-Bois 20, 1215, Geneva 15, Switzerland. .; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Feb 28; Vol. 23 (1), pp. 61. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/adverse effects
Artemisinins*/adverse effects
Malaria, Falciparum*/drug therapy
Malaria*/drug therapy
Artesunate*
Naphthyridines*
Child ; Humans ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Artemether/therapeutic use ; Randomized Controlled Trials as Topic ; Drug Combinations ; Treatment Outcome ; Vomiting/chemically induced ; Vomiting/drug therapy ; Ethanolamines/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Antibiotic prophylaxis with piperacillin-tazobactam reduces organ/space surgical site infection after pancreaticoduodenectomy: a retrospective and propensity score-matched analysis.
Autorzy:: Yang Y; Division of Pancreatic Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Sheng J; Division of Pancreatic Surgery, Department of General Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, China.
Cai Z; Division of Pancreatic Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Zhu L; Division of Pancreatic Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Lu C; Division of Pancreatic Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Mao L; Division of Pancreatic Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Qiu Y; Division of Pancreatic Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China. .; Division of Pancreatic Surgery, Department of General Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, China. .; Department of General Surgery, Pancreatic Disease Center, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210002, China. .
Fu X; Division of Pancreatic Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China. .; Department of General Surgery, Pancreatic Disease Center, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210002, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Feb 23; Vol. 24 (1), pp. 251. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Surgical Wound Infection*/epidemiology
Surgical Wound Infection*/etiology
Surgical Wound Infection*/prevention & control
Antibiotic Prophylaxis*/adverse effects
Humans ; Retrospective Studies ; Ceftriaxone ; Pancreaticoduodenectomy/adverse effects ; Propensity Score ; Anti-Bacterial Agents/therapeutic use ; Piperacillin, Tazobactam Drug Combination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Emergence of multidrug-resistant Bacillus spp. derived from animal feed, food and human diarrhea in South-Eastern Bangladesh.
Autorzy:: Haque MA; National Key Laboratory of Veterinary Public Health Security, College of Veterinary Medicine, China Agricultural University, Beijing, 100019, China.; Department of Microbiology, Faculty of Veterinary and Animal Science, Hajee Mohammad Danesh Science and Technology University, Dinajpur, 5200, Bangladesh.
Hu H; National Key Laboratory of Veterinary Public Health Security, College of Veterinary Medicine, China Agricultural University, Beijing, 100019, China.
Liu J; National Key Laboratory of Veterinary Public Health Security, College of Veterinary Medicine, China Agricultural University, Beijing, 100019, China.
Islam MA; Department of Microbiology, Faculty of Science, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Hossen F; Department of Microbiology, Faculty of Science, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Rahman MA; Department of Microbiology, Faculty of Science, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Ahmed F; Department of Microbiology, Faculty of Science, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh. .
He C; National Key Laboratory of Veterinary Public Health Security, College of Veterinary Medicine, China Agricultural University, Beijing, 100019, China. .; Pokaż więcej
Źródło:: BMC microbiology [BMC Microbiol] 2024 Feb 19; Vol. 24 (1), pp. 61. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:: Journal Article
MeSH Terms:: Bacillus*/genetics
Humans ; Animals ; Trimethoprim, Sulfamethoxazole Drug Combination ; Amoxicillin-Potassium Clavulanate Combination ; Bangladesh/epidemiology ; Anti-Bacterial Agents/pharmacology ; Diarrhea ; Penicillins ; Animal Feed ; Microbial Sensitivity Tests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Forensic investigation of falsified antimalarials using isotope ratio mass spectrometry: a pilot investigation.
Autorzy:: Newton PN; Lao-Oxford-Mahosot Hospital-Wellcome Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR. .; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. .; Infectious Diseases Data Observatory, Nuffield Department of Medicine, University of Oxford, Oxford, UK. .
Chesson LA; IsoForensics, Inc, Salt Lake City, UT, USA.
Mayxay M; Lao-Oxford-Mahosot Hospital-Wellcome Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Institute of Research and Education Development (IRED), University of Health Sciences, Ministry of Health, Vientiane, Lao PDR.
Dondorp A; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Mahidol Oxford Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Tabernero P; Lao-Oxford-Mahosot Hospital-Wellcome Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Infectious Diseases Data Observatory, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Public Health Unit, Faculty of Medicine, Universidad de Alcalá, Alcalá de Henares, Spain.
Howa JD; IsoForensics, Inc, Salt Lake City, UT, USA.
Cerling TE; IsoForensics, Inc, Salt Lake City, UT, USA.; Department of Geology and Geophysics and Department of Biology, University of Utah, Salt Lake City, UT, USA.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 18; Vol. 14 (1), pp. 3995. Date of Electronic Publication: 2024 Feb 18.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/therapeutic use
Artesunate ; Pilot Projects ; Artemether ; Artemether, Lumefantrine Drug Combination ; Mass Spectrometry/methods ; Isotopes ; Starch ; Water

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Prevalence, regional distribution, and trends of antimicrobial resistance among female outpatients with urine Klebsiella spp. isolates: a multicenter evaluation in the United States between 2011 and 2019.
Autorzy:: Kaye KS; Division of Allergy, Immunology and Infectious Diseases, Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Gupta V; MMS Medical Affairs, Becton, Dickinson and Company, Franklin Lakes, NJ, USA.
Mulgirigama A; Antibiotics, GSK, Brentford, London, UK.
Joshi AV; Value Evidence and Outcomes, GSK, Collegeville, PA, USA.
Ye G; Software Technology Solutions, Becton, Dickinson and Company, Franklin Lakes, NJ, USA.
Scangarella-Oman NE; Diagnostics and Clinical Microbiology, GSK, Collegeville, PA, USA.
Yu K; Medical and Scientific Affairs, Becton, Dickinson and Company, Franklin Lakes, NJ, USA.
Mitrani-Gold FS; Epidemiology, GSK, Collegeville, PA, USA. .; Pokaż więcej
Źródło:: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2024 Feb 14; Vol. 13 (1), pp. 21. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Klebsiella*
Urinary Tract Infections*/epidemiology
Urinary Tract Infections*/drug therapy
Female ; Humans ; Anti-Bacterial Agents/pharmacology ; beta-Lactamases/genetics ; Drug Resistance, Bacterial ; Escherichia coli ; Klebsiella pneumoniae ; Nitrofurantoin/pharmacology ; Outpatients ; Prevalence ; Retrospective Studies ; Trimethoprim, Sulfamethoxazole Drug Combination ; United States/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Effectiveness of artemether-lumefantrine for treating uncomplicated malaria in low- and high-transmission areas of Ghana.
Autorzy:: Mawuli MA; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Legon, Accra, Ghana. .; Department of Pathology, University of Ghana Medical School, College of Health Sciences, University of Ghana, Korle-Bu, Accra, Ghana. .
Amoah LE; Department of Immunology, Noguchi Memorial Institute for Medical Research College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
Cui L; Department of Internal Medicine, University of South Florida, 3720 Spectrum Blvd, Tampa, FL, 33612, USA.
Quashie NB; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Legon, Accra, Ghana.; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.; Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, University of Ghana, Korle-Bu, Accra, Ghana.
Afrane YA; Department of Medical Microbiology, University of Ghana Medical School College of Health Sciences, University of Ghana, Korle-Bu, Accra, Ghana.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Feb 05; Vol. 23 (1), pp. 40. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/therapeutic use
Artemisinins*/therapeutic use
Malaria, Falciparum*/drug therapy
Humans ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Ghana ; Drug Combinations ; Artemether/therapeutic use ; Recurrence ; Parasitemia/drug therapy ; Ethanolamines/therapeutic use ; Fluorenes/therapeutic use ; Plasmodium falciparum/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Factors associated with frequent buprenorphine / naloxone initiation in a national survey of Canadian emergency physicians.
Autorzy:: MacKinnon N; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Emergency Medicine, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Lane D; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
Scheuermeyer F; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Emergency Medicine, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Center for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada.
Kaczorowski J; Université de Montréal, Montreal, Quebec, Canada.
Dong K; Department of Emergency Medicine, University of Alberta, Edmonton, Alberta, Canada.
Orkin AM; Department of Family & Community Medicine, University of Toronto, Toronto, Ontario, Canada.
Daoust R; Université de Montréal, Montreal, Quebec, Canada.; Centre de Recherche de l'Hôpital Sacré-Coeur de Montréal, Montreal, Quebec, Canada.
Moe J; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Andolfatto G; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
Klaiman M; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Yan J; Division of Emergency Medicine, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Koh JJ; Department of Emergency Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Crowder K; Department of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada.
Atkinson P; Department of Emergency Medicine, Dalhousie University, St. John, New Brunswick, Canada.
Savage D; Division of Clinical Sciences, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Stempien J; Department of Emergency Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Besserer F; Department of Emergency Medicine, University of British Columbia, Prince George, British Columbia, Canada.
Wale J; Department of Emergency Medicine, University of British Columbia, Victoria, British Columbia, Canada.
Kestler A; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Emergency Medicine, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Center for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada.; British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 05; Vol. 19 (2), pp. e0297084. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Buprenorphine*/therapeutic use
Opioid-Related Disorders*/drug therapy
Opioid-Related Disorders*/epidemiology
Opioid-Related Disorders*/complications
Humans ; Narcotic Antagonists/therapeutic use ; Canada/epidemiology ; Buprenorphine, Naloxone Drug Combination/therapeutic use ; Emergency Service, Hospital ; Cognition ; Naloxone/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Effectiveness of the Eutectic Mixture of Local Anaesthetics Cream in the Management of Arteriovenous Fistula Needle Insertion Pain in Patients Undergoing Haemodialysis.
Autorzy:: Shahri HA; Renal Medicine Department, Sultan Qaboos Hospital, Salalah, Oman.
Salmi IA; Department of Renal Medicine, The Royal Hospital, Muscat, Oman.
Rajhi WA; College of Pharmacy and Nursing, Nizwa University, Nizwa, Oman.
Shemshaki H; Department of Urology, The Royal Hospital, Muscat, Oman.; Pokaż więcej
Źródło:: Sultan Qaboos University medical journal [Sultan Qaboos Univ Med J] 2024 Feb; Vol. 24 (1), pp. 7-19. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Anesthetics, Local*/therapeutic use
Arteriovenous Fistula*
Adult ; Humans ; Lidocaine, Prilocaine Drug Combination ; Renal Dialysis ; Emollients ; Pain/drug therapy ; Pain/etiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Clinical and immunological outcomes of HIV-exposed uninfected and HIV-unexposed uninfected children in the first 24 months of life in Western Kenya.
Autorzy:: Ray JE; Center for Global Health & Diseases, Case Western Reserve University, 10900 Euclid Avenue LC: 4983, Cleveland, OH, 44106, USA.
Dobbs KR; Center for Global Health & Diseases, Case Western Reserve University, 10900 Euclid Avenue LC: 4983, Cleveland, OH, 44106, USA. .; Division of Pediatric Infectious Diseases, University Hospitals Rainbow Babies and Children's Hospital, LC: 4983, Cleveland, OH, 44106, USA. .
Ogolla SO; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Daud II; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Midem D; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Omenda MM; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Nowacki AS; Department of Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
Beeson JG; Burnet Institute, Melbourne, VIC, Australia.
Sabourin KR; Department of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Rochford R; Department of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Dent AE; Center for Global Health & Diseases, Case Western Reserve University, 10900 Euclid Avenue LC: 4983, Cleveland, OH, 44106, USA. .; Division of Pediatric Infectious Diseases, University Hospitals Rainbow Babies and Children's Hospital, LC: 4983, Cleveland, OH, 44106, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 01; Vol. 24 (1), pp. 156. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/therapeutic use
HIV Infections*/complications
Malaria*/drug therapy
Malaria*/complications
Vaccines*/therapeutic use
Child ; Pregnancy ; Female ; Humans ; Infant ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use ; Kenya/epidemiology ; Antibodies ; Cytokines

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Disseminated Nocardia nova in a child with relapsed acute lymphoblastic leukemia: a case report.
Autorzy:: Arahirwa V; University of North Carolina School of Medicine, Chapel Hill, USA. victor_.
Thahir S; University of North Carolina School of Medicine, Chapel Hill, USA.
Hernandez L; University of North Carolina School of Medicine, Chapel Hill, USA.
Willis ZI; University of North Carolina School of Medicine, Chapel Hill, USA.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 01; Vol. 24 (1), pp. 154. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Nocardia*
Nocardia Infections*/diagnosis
Nocardia Infections*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Male ; Child ; Humans ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use ; Anti-Bacterial Agents/therapeutic use
SCR Organism:: Nocardia nova

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: A striking presentation of pustular Sweet syndrome induced by trimethoprim-sulfamethoxazole.
Autorzy:: Ryder CY; University of Michigan Medical School, Ann Arbor, Michigan, USA.
Matthews NH; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Lowe L; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Wang F; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Pokaż więcej
Źródło:: The Australasian journal of dermatology [Australas J Dermatol] 2022 Nov; Vol. 63 (4), pp. e356-e359. Date of Electronic Publication: 2022 Jul 22.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Trimethoprim, Sulfamethoxazole Drug Combination*/adverse effects
Sweet Syndrome*/chemically induced
Sweet Syndrome*/diagnosis
Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""drug combination"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język